Literature DB >> 19144771

Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2.

David B Buckley1, Curtis D Klaassen.   

Abstract

UDP-glucuronosyltransferases (UGTs) catalyze the addition of UDP-glucuronic acid to endo- and xenobiotics, enhancing their water solubility and elimination. Many exogenous compounds, such as microsomal enzyme inducers (MEIs), alter gene expression through xenobiotic-responsive transcription factors, namely, the aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), pregnane X receptor (PXR), peroxisome proliferator-activated receptor alpha (PPARalpha), and nuclear factor erythroid 2-related factor 2 (Nrf2). These transcription factors regulate xenobiotic-inducible expression of hepatic and intestinal biotransformation enzymes and transporters. The purpose of this study was to determine hepatic and intestinal inducibility of mouse Ugt mRNA by MEIs. Male C57BL/6 mice were treated for four consecutive days with activators of AhR [2,3,7,8-tetrachlorodibenzodioxin (TCDD), polychlorinated biphenyl 126, and beta-naphthoflavone], CAR [1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP), phenobarbital, and diallyl sulfide], PXR [pregnenolone-16alpha-carbonitrile (PCN), spironolactone, and dexamethasone], PPARalpha (clofibrate, ciprofibrate, and diethylhexylphthalate), and Nrf2 (oltipraz, ethoxyquin, and butylated hydroxyanisole), respectively. Ugt1a1 mRNA expression in liver was induced by activators of all five transcription factor pathways, Ugt1a5 by Nrf2 activators, Ugt1a6 by all the pathways except CAR, and Ugt1a9 by all the pathways except Nrf2. Ugt2b35 mRNA in liver was induced by AhR activators and Ugt2b36 by CAR and PPARalpha activators. Throughout the small and large intestine, the AhR ligand TCDD increased Ugt1a6 and Ugt1a7 mRNA. In small intestine, the PXR activator PCN increased Ugt1a1, Ugt1a6, Ugt1a7, Ugt2b34, and Ugt2b35 mRNA in the duodenum. In conclusion, chemical activation of AhR, CAR, PXR, PPARalpha, and Nrf2 in mouse results in induction of distinct Ugt gene sets in liver and intestine, predominantly the Ugt1a isoforms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144771      PMCID: PMC2680533          DOI: 10.1124/dmd.108.024190

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  42 in total

Review 1.  A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection.

Authors:  J Sonoda; J M Rosenfeld; L Xu; R M Evans; W Xie
Journal:  Curr Drug Metab       Date:  2003-02       Impact factor: 3.731

2.  Mechanism of rat UDP-glucuronosyltransferase 1A6 induction by oltipraz: evidence for a contribution of the Aryl hydrocarbon receptor pathway.

Authors:  Diana J Auyeung; Fay K Kessler; Joseph K Ritter
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

3.  Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.

Authors:  M Ramos-Gomez; M K Kwak; P M Dolan; K Itoh; M Yamamoto; P Talalay; T W Kensler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Detection of chemical-induced differential expression of rat hepatic cytochrome P450 mRNA transcripts using branched DNA signal amplification technology.

Authors:  D P Hartley; C D Klaassen
Journal:  Drug Metab Dispos       Date:  2000-05       Impact factor: 3.922

Review 5.  UDP-glucuronosyltransferases.

Authors:  C D King; G R Rios; M D Green; T R Tephly
Journal:  Curr Drug Metab       Date:  2000-09       Impact factor: 3.731

6.  Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice.

Authors:  David B Buckley; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2006-10-18       Impact factor: 3.922

7.  High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes.

Authors:  A Enomoto; K Itoh; E Nagayoshi; J Haruta; T Kimura; T O'Connor; T Harada; M Yamamoto
Journal:  Toxicol Sci       Date:  2001-01       Impact factor: 4.849

8.  Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR.

Authors:  W Xie; J L Barwick; C M Simon; A M Pierce; S Safe; B Blumberg; P S Guzelian; R M Evans
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

9.  The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR.

Authors:  J Sugatani; H Kojima; A Ueda; S Kakizaki; K Yoshinari; Q H Gong; I S Owens; M Negishi; T Sueyoshi
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

10.  Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray.

Authors:  Rajesh K Thimmulappa; Kim H Mai; Sorachai Srisuma; Thomas W Kensler; Masayuki Yamamoto; Shyam Biswal
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

View more
  51 in total

Review 1.  Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR.

Authors:  Antonia H Tolson; Hongbing Wang
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

2.  Isoform-Specific Regulation of Mouse Carboxylesterase Expression and Activity by Prototypical Transcriptional Activators.

Authors:  Angela A Baker; Grace L Guo; Lauren M Aleksunes; Jason R Richardson
Journal:  J Biochem Mol Toxicol       Date:  2015-07-15       Impact factor: 3.642

3.  Ortho-aminoazotoluene activates mouse constitutive androstane receptor (mCAR) and increases expression of mCAR target genes.

Authors:  Mariya A Smetanina; Mariya Y Pakharukova; Svitlana M Kurinna; Bingning Dong; Juan P Hernandez; David D Moore; Tatyana I Merkulova
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-06       Impact factor: 4.219

4.  Regulation of hepatic phase II metabolism in pregnant mice.

Authors:  Xia Wen; Ajay C Donepudi; Paul E Thomas; Angela L Slitt; Roberta S King; Lauren M Aleksunes
Journal:  J Pharmacol Exp Ther       Date:  2012-10-10       Impact factor: 4.030

5.  Ciprofibrate regulation of rat hepatic bilirubin glucuronidation and UDP-glucuronosyltransferases expression.

Authors:  Jean-Marie Heydel; Philippe Garnier; Philippe Faure; Yves Artur
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-04-04       Impact factor: 2.441

6.  Induction of the UDP-Glucuronosyltransferase 1A1 during the Perinatal Period Can Cause Neurodevelopmental Toxicity.

Authors:  Rika Hirashima; Hirofumi Michimae; Hiroaki Takemoto; Aya Sasaki; Yoshinori Kobayashi; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Mol Pharmacol       Date:  2016-07-13       Impact factor: 4.436

Review 7.  Complexity of vitamin E metabolism.

Authors:  Lisa Schmölz; Marc Birringer; Stefan Lorkowski; Maria Wallert
Journal:  World J Biol Chem       Date:  2016-02-26

8.  UDP-glucuronosyltransferase expression in mouse liver is increased in obesity- and fasting-induced steatosis.

Authors:  Jialin Xu; Supriya R Kulkarni; Liya Li; Angela L Slitt
Journal:  Drug Metab Dispos       Date:  2011-10-26       Impact factor: 3.922

9.  Activation of Constitutive Androstane Receptor (CAR) in Mice Results in Maintained Biliary Excretion of Bile Acids Despite a Marked Decrease of Bile Acids in Liver.

Authors:  Andrew J Lickteig; Iván L Csanaky; Matthew Pratt-Hyatt; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2016-03-16       Impact factor: 4.849

Review 10.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2012-12-05       Impact factor: 4.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.